The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a single-award indefinite delivery contract (IDC) worth up to $48,025,600 to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the supply of the Japanese encephalitis vaccine IXIARO to support the Department of Defense's medical countermeasures program. Through a series of firm fixed-price delivery orders issued under this IDC,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a series of firm fixed price delivery order contracts to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contracts, which have a total ceiling value exceeding $50 million, were issued against Valneva USA's existing indefinite-delivery/indefinite-quantity (IDIQ) vehicles and support the DLA's mission to provide critical medical...
The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Valneva USA, Inc. for the supply of Japanese encephalitis vaccine. Multiple firm fixed price delivery orders were issued against this contract vehicle for vaccine production and delivery from Valneva's Potomac, Maryland facility. Delivery orders ranged from approximately $2.7 million to $17.8 million, covering periods of performance from 2021 through 2023. The original solicitation sought proposals...
Summary: This Federal Supply Schedule (FSS) contract award to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE, is for the delivery of the Japanese Encephalitis Virus Vaccine (IXIARO) to various federal civilian agencies. The contract has a ceiling value of $225,000 and was awarded on December 15, 2016, with an ultimate completion date of October 30, 2025. The contract is parent to multiple firm fixed-price delivery...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency's Medical Supply Chain unit to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development and delivery. The contract, valued at $36,120,112.50, aims to procure approximately 3.23 million doses of injectable influenza virus vaccines in multi-dose vials and pre-filled syringes for various age groups, including elderly, adult, and pediatric populations. The vaccines are intended...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency Troop Support Medical to Seqirus USA Inc., a global biotechnology company specializing in influenza vaccine development, manufacturing, and delivery. The $27.5M IDC, which has a period of performance through June 2019, aims to procure approximately 3.6 million doses of injectable influenza vaccine in multi-dose vials and pre-filled syringes for various ages, including pediatric formulations. The contract supports...
The Department of Veterans Affairs National Acquisition Center awarded a single award IDV to Seqirus USA Inc. on March 15, 2021 with a potential value of $67,604,685.53. Task orders issued against the IDV by the VA, Bureau of Prisons, Indian Health Service, and James A. Lovell Federal Healthcare Center procure influenza virus vaccines for the 2021-2022 season. Vaccines provided under the IDV and related task orders include those in multi-dose vials and single dose syringes for adults and...
This Indefinite Delivery Contract (IDC) was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and medical goods. The IDC has a ceiling value of $645,550.20 and an ultimate completion date of November 13, 2024. Sanofi Pasteur Inc. has previously received awards from various federal agencies to supply vaccines and other medical countermeasures through IDVs and Federal Supply...
The Indefinite Delivery Contract (IDC) awarded to Sanofi Pasteur Inc. by the National Acquisition Center, a component of the Department of Veterans Affairs (VA), is for the procurement of Influenza Virus Vaccine for the 2025-2026 influenza season. The contract has a Period of Performance from March 15, 2025 to March 14, 2026, and a ceiling value of $113,670.50. As the prime contractor, Sanofi Pasteur Inc. will provide seasonal influenza vaccines to support requirements for the VA, State...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The 5-year contract, valued at up to $4,023,280.80, is for the provision of Influenza Virus Vaccines in support of public health preparedness missions. Sanofi Pasteur holds multiple IDVs with various federal agencies, including the Department of Health and Human Services, Centers for Disease Control and Prevention, and...